Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung function in beta-thalassemia patients: a longitudinal study.

G Piatti1, L Allegra, V Fasano

  • 1Istituto di Tisiologia e delle Malattie dell'Apparato Respiratorio, Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Fondazione IRCCS, Milano, Italia. gioia.piatti@unimi.it

Acta Haematologica
|July 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two-meshes approach in posterior component separation with transversus abdominis release: the IMPACT study (Italian Multicentric Posterior-separation Abdominal Complex hernia Transversus-release).

Hernia : the journal of hernias and abdominal wall surgery·2024
Same author

Gentle Giant? Giant Gastric Solitary Peutz-Jeghers Polyp.

Digestive diseases and sciences·2024
Same author

IPOM plus versus IPOM standard in incisional hernia repair: results of a prospective multicenter trial.

Hernia : the journal of hernias and abdominal wall surgery·2023
Same author

Stemming the Leak: A Novel Treatment for Gastro-Bronchial Fistula.

Digestive diseases and sciences·2022
Same author

Cardiopulmonary testing in adult patients with β-thalassemia major in comparison to healthy subjects.

Annals of hematology·2022
Same author

Selective delivery of pentamidine toward cancer cells by self-assembled nanoparticles.

International journal of pharmaceutics·2022
Same journal

Dapagliflozin in Patients with homozygous β-Thalassemia and Albuminuria.

Acta haematologica·2026
Same journal

Efficacy of second-generation FLT3 inhibitors in FLT3-mutated AML: A meta-analysis of randomized controlled trials.

Acta haematologica·2026
Same journal

Limited prognostic value of ELN classification and relevance of molecular ontogeny in acute myeloid leukemia post myeloproliferative neoplasms: a retrospective multicenter study.

Acta haematologica·2026
Same journal

Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data Collection.

Acta haematologica·2026
Same journal

Comparative efficacy of donor lymphocyte infusions in augmenting graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies.

Acta haematologica·2026
Same journal

COVID-19 infection in patients with follicular lymphoma and related indolent B-cell lymphomas receiving anti-CD20 monoclonal antibody maintenance therapy.

Acta haematologica·2026
See all related articles

Pulmonary function tests (PFTs) in beta-thalassemia patients show abnormalities, but lung function remains stable over time. Optimal iron balance through chelation therapy may improve PFT results.

Area of Science:

  • Pulmonary Medicine
  • Hematology
  • Genetics

Background:

  • Beta-thalassemia is associated with pulmonary function abnormalities.
  • The long-term pulmonary function changes in beta-thalassemia patients are not well understood.

Purpose of the Study:

  • To investigate the longitudinal changes in pulmonary function tests (PFTs) in asymptomatic beta-thalassemia patients.
  • To identify predictors of PFT abnormalities in this population.

Main Methods:

  • A longitudinal study involving 18 beta-thalassemia major and 11 beta-thalassemia intermedia patients.
  • Pulmonary function tests (including spirometry, body plethysmography, and DL(CO)) were conducted in 1996 and 2003.
  • Echocardiography was used to rule out pulmonary hypertension.

Related Experiment Videos

Main Results:

  • In 1996, 55.5% of major and 45.4% of intermediate beta-thalassemia patients had restrictive PFT patterns.
  • By 2003, the prevalence decreased to 38.8% and 27.2%, respectively.
  • Carbon monoxide diffusion capacity (DL(CO)) remained stable, reduced in some major but normal in intermediate patients.

Conclusions:

  • Asymptomatic beta-thalassemia patients exhibit a high prevalence of PFT abnormalities, which do not significantly worsen over time.
  • Improved PFT outcomes may be linked to effective iron chelation therapy and maintaining iron balance.